Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut du Cancer de Montpellier - Val d'Aurelle
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Breast adenocarcinoma should receive 6 cycles of adjuvant chemotherapy
Women ≥ 18 years old (no age limit)
Performance status :0 or 1
Patients must be affiliated to a Social Security System
Signed informed consent obtained before any study specific procedures.
Vitamin D deficiency confirmed ( vitamin D result must be \< at 30 ng/ml)
You may not be if
Metastatic disease
Patients with previous or concomitant other (not breast cancer) malignancy within the past 5 years EXCEPT adequately treated basal or squamous cell carcinoma of the skin or in situ carcinoma of the cervix. Patients who have had a previous other malignancy must have been disease free for at least five years
calcium or colecalciferol contraindications (vitamin D hypersensitivity - disease or an other condition result in hypercalcaemia or hypercalciuria -Calcic lithiasis- high vitamin D level)
Presence of the following diseases in the last 3 years : endocrinal disease, A phosphor calcic disorder treated by vitamin D supplementation at 1000 UI/day or more (this patient who have received a dose \< 1000 UI/day, will be included after have to stop Vitamin D at least 48 hours ) - Osteopenia or osteoporosis confirmed treated
Concomittant treatment with an other experimental product
Pregnant or breastfeeding women
Legal incapacity or physical, psychological or mental status interfering with the patient's ability to sign the informed consent or to terminate the study.
